{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:25:56Z","timestamp":1772166356067,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The aim of this study was to determine whether the treatment with doxycycline before and after oocyte retrieval is as effective as salpingectomy in minimizing the detrimental effect of hydrosalpinx on the outcomes of IVF-ET.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective analysis was done for the outcomes of the IVF-ET cycles of patients with hydrosalpinx who underwent laparoscopic salpingectomy prior to IVF cycle (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009260) or were treated with extended doxycycline treatment during the IVF cycle (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200945). In doxycycline group, doxycycline (100\u2009mg twice daily) was started 1 week before anticipated oocyte retrieval and was continued for 1 week after oocyte retrieval. In salpingectomy group, the mesosalpinx was coagulated as close as possible to the fallopian tube.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The implantation, clinical pregnancy, ongoing pregnancy and live birth rates were significantly higher in the salpingectomy group (20.87% Vs. 9.91%,\n                      <jats:italic>P<\/jats:italic>\n                      value =0.007, 44.62% Vs. 20%,\n                      <jats:italic>P<\/jats:italic>\n                      value\u2009=\u20090.002, 39.62% Vs. 17.78%,\n                      <jats:italic>P<\/jats:italic>\n                      value\u2009=\u20090.005 and 37.31% Vs. 15.56%,\n                      <jats:italic>P<\/jats:italic>\n                      value\u2009=\u20090.005 respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Salpingectomy is more effective than extended doxycycline treatment in improving the outcomes of IVF-ET in patients with hydrosalpinx undergoing IVF-ET. Further, larger well designed randomized controlled trials should be conducted to confirm the findings of this study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13048-020-00665-0","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T13:02:40Z","timestamp":1591966960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Extended doxycycline treatment versus salpingectomy in the management of patients with\u00a0hydrosalpinx undergoing IVF-ET"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5002-4188","authenticated-orcid":false,"given":"Usama M.","family":"Fouda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham S.","family":"Elshaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma F.","family":"Darweesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,12]]},"reference":[{"key":"665_CR1","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1093\/oxfordjournals.humrep.a138362","volume":"9","author":"AN Andersen","year":"1994","unstructured":"Andersen AN, Yue Z, Meng FJ, Petersen K. Low implantation rate after in-vitro fertilization in patients with hydrosalpinges diagnosed by ultrasonography. Hum Reprod. 1994;9:1935\u20138.","journal-title":"Hum Reprod"},{"key":"665_CR2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/oxfordjournals.humrep.a138606","volume":"9","author":"A Strandell","year":"1994","unstructured":"Strandell A, Waldenstrom U, Nilsson L, Hamberger L. Hydrosalpinx reduces in-vitro fertilization\/embryo transfer pregnancy rates. Hum Reprod. 1994;9:861\u20133.","journal-title":"Hum Reprod"},{"key":"665_CR3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/humrep\/14.5.1243","volume":"14","author":"E Camus","year":"1999","unstructured":"Camus E, Poncelet C, Goffinet F, Wainer B, Merlet F, Nisand I, et al. Pregnancy rates after in-vitro fertilizationin cases of tubal infertility with and without hydrosalpinx:a meta-analysis of published comparative studies. Hum Reprod. 1999;14:1243\u20139.","journal-title":"Hum Reprod"},{"key":"665_CR4","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/HUMREP\/11.3.523","volume":"11","author":"KE Shelton","year":"1996","unstructured":"Shelton KE, Butler L, Toner JP, Oehninger S, Muasher SJ. Salpingectomy improves the pregnancy rate in in-vitro fertilization patients with hydrosalpinx. Hum Reprod. 1996;11:523\u20135.","journal-title":"Hum Reprod"},{"key":"665_CR5","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1093\/humrep\/14.11.2762","volume":"14","author":"A Strandell","year":"1999","unstructured":"Strandell A, Lindhard A, Waldenstrom U, Thorburn J, Janson PO, Hamberger L. Hydrosalpinx and IVF outcome: a prospective, randomized multicentre trial in Scandinavia onsalpingectomy prior to IVF. Hum Reprod. 1999;14:2762\u20139.","journal-title":"Hum Reprod"},{"key":"665_CR6","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/humrep\/17.3.543","volume":"17","author":"NP Johnson","year":"2002","unstructured":"Johnson NP, Mak W, Sowter MC. Laparoscopic salpingectomy for women with hydrosalpinges enhances the success of IVF: a Cochrane review. Hum Reprod. 2002;17:543\u20138.","journal-title":"Hum Reprod"},{"issue":"8","key":"665_CR7","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3109\/09513590.2010.507290","volume":"27","author":"UM Fouda","year":"2011","unstructured":"Fouda UM, Sayed AM. Effect of ultrasound-guided aspiration of hydrosalpingeal fluid during oocyte retrieval on the outcomes of in vitro fertilisation-embryo transfer: a randomised controlled trial (NCT01040351). Gynecol Endocrinol. 2011;27(8):562\u20137.","journal-title":"Gynecol Endocrinol"},{"key":"665_CR8","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.fertnstert.2007.01.050","volume":"88","author":"JA Hitkari","year":"2007","unstructured":"Hitkari JA, Singh SS, Shapiro HM, Leyland N. Essure treatment of hydrosalpinges. Fertil Steril. 2007;88:1663\u20136.","journal-title":"Fertil Steril"},{"issue":"6","key":"665_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3109\/01443615.2014.985768","volume":"35","author":"S D'Arpe","year":"2015","unstructured":"D'Arpe S, Franceschetti S, Caccetta J, Pietrangeli D, Muzii L, Panici PB. Management of hydrosalpinx before IVF: a literature review. J Obstet Gynaecol. 2015;35(6):547\u201350.","journal-title":"J Obstet Gynaecol"},{"key":"665_CR10","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S0015-0282(01)01753-8","volume":"75","author":"BS Hurst","year":"2001","unstructured":"Hurst BS, Tucker KE, Awoniyi CA, Schlaff WD. Hydrosalpinx treated with extended doxycycline does not compromise the success of in vitro fertilization. Fertil Steril. 2001;75:1017\u20139.","journal-title":"Fertil Steril"},{"issue":"12","key":"665_CR11","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3109\/09513590.2011.579661","volume":"27","author":"U Fouda","year":"2011","unstructured":"Fouda U, Sayed A. Extended high dose letrozole regimen versus short low dose letrozole regimen as an adjuvant to gonadotropin releasing hormone antagonist protocol in poor responders undergoing IVF-ET*. Gynecol Endocrinol. 2011;27(12):1018\u201322.","journal-title":"Gynecol Endocrinol"},{"key":"665_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/humrep\/17.2.351","volume":"17","author":"LW Chien","year":"2002","unstructured":"Chien LW, Au HK, Xiao J, Tzeng CR. Fluid accumulation within the uterine cavity reduces pregnancy rates in women undergoing IVF. Hum Reprod. 2002;17:351\u20136.","journal-title":"Hum Reprod"},{"key":"665_CR13","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/humrep\/deh737","volume":"20","author":"MA Akman","year":"2005","unstructured":"Akman MA, Erden HF, Bahceci M. Endometrial fluid visualized through ultrasonography during ovarian stimulation in IVF cycles impairs the outcome in tubal factor, but not PCOS, patients. Hum Reprod. 2005;20:906\u20139.","journal-title":"Hum Reprod"},{"key":"665_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12905-015-0177-2","volume":"15","author":"UM Fouda","year":"2015","unstructured":"Fouda UM, Sayed AM, Abdelmoty HI, Elsetohy KA. Ultrasound guided aspiration of hydrosalpinx fluid versus salpingectomy in the management of patients with ultrasound visible hydrosalpinx undergoing IVF-ET: a randomized controlled trial. BMC Womens Health. 2015;15:21.","journal-title":"BMC Womens Health"},{"issue":"3","key":"665_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/humupd\/8.3.255","volume":"8","author":"LC Ajonuma","year":"2002","unstructured":"Ajonuma LC, Ng EH, Chan HC. New insights into the mechanisms underlying hydrosalpinx fluid formation and its adverse effect on IVF outcome. Hum Reprod Update. 2002;8(3):255\u201364.","journal-title":"Hum Reprod Update"},{"key":"665_CR16","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1093\/humrep\/13.10.2921","volume":"13","author":"A Strandell","year":"1998","unstructured":"Strandell A, Sjogren A, Bentin-Ley U, Thorburn J, Hamberger L, Brannstrom M. Hydrosalpinx fluid does not adversely affect the normal development of human embryos and implantation in vitro. Hum Reprod. 1998;13:2921\u20135.","journal-title":"Hum Reprod"},{"issue":"6","key":"665_CR17","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1093\/humrep\/13.6.1620","volume":"13","author":"I Granot","year":"1998","unstructured":"Granot I, Dekel N, Segal I, Fieldust S, Shoham Z, Barash A. Is hydrosalpinx fluid cytotoxic? Hum Reprod. 1998;13(6):1620\u20134.","journal-title":"Hum Reprod"},{"issue":"3","key":"665_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/0002-9378(69)90270-1","volume":"105","author":"A David","year":"1969","unstructured":"David A, Garcia CR, Czernobilsky B. Human hydrosalpinx. Histologic study and chemical composition of fluid. Am J Obstet Gynecol. 1969;105(3):400\u201311.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"665_CR19","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/humrep\/17.3.601","volume":"17","author":"MA Bedaiwy","year":"2002","unstructured":"Bedaiwy MA, Goldberg JM, Falcone T, Singh M, Nelson D, Azab H, et al. Relationship between oxidative stress and embryotoxicity of hydrosalpingeal fluid. Hum Reprod. 2002;17(3):601\u20134.","journal-title":"Hum Reprod"},{"key":"665_CR20","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1067\/mob.2002.121728","volume":"186","author":"LO Eckert","year":"2002","unstructured":"Eckert LO, Hawes SE, W\u00f6lner-Hanssen PK, Kiviat NB, Wasserheit JN, Paavonen JA, et al. Endometritis. The clinical-pathologic syndrome. Am J Obstet Gynecol. 2002;186:690\u20135.","journal-title":"Am J Obstet Gynecol"},{"key":"665_CR21","doi-asserted-by":"publisher","first-page":"e12719","DOI":"10.1111\/aji.12719","volume":"78","author":"K Kitaya","year":"2017","unstructured":"Kitaya K, Matsubayashi H, Takaya Y, Nishiyama R, Yamaguchi K, Takeuchi T, et al. Live birth rate following oral antibiotic treatment for chronic endometritis in infertile women with repeated implantation failure. Am J Reprod Immunol. 2017;78:e12719.","journal-title":"Am J Reprod Immunol"},{"key":"665_CR22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/humrep\/deu292","volume":"30","author":"E Cicinelli","year":"2015","unstructured":"Cicinelli E, Matteo M, Tinelli R, Lepera A, Alfonso R, Indraccolo U, et al. Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy. Hum Reprod. 2015;30:323\u201330.","journal-title":"Hum Reprod"},{"key":"665_CR23","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/humrep\/12.7.1393","volume":"12","author":"WR Meyer","year":"1997","unstructured":"Meyer WR, Castelbaum AJ, Somkuti S, Sagoskin AW, Doyle M, Harris JE, et al. Hydrosalpinges adversely affect markers of endometrial receptivity. Hum Reprod. 1997;12:1393\u20138.","journal-title":"Hum Reprod"},{"issue":"11","key":"665_CR24","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1093\/humrep\/dei188","volume":"20","author":"E Seli","year":"2005","unstructured":"Seli E, Kayisli UA, Cakmak H, Bukulmez O, Bildirici I, Guzeloglu-Kayisli O, et al. Removal of hydrosalpinges increases endometrial leukaemia inhibitory factor (LIF) expression at the time of the implantation window. Hum Reprod. 2005;20(11):3012\u20137.","journal-title":"Hum Reprod"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-020-00665-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-020-00665-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-020-00665-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T19:34:35Z","timestamp":1623440075000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-020-00665-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,12]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["665"],"URL":"https:\/\/doi.org\/10.1186\/s13048-020-00665-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-24073\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-24073\/v2","asserted-by":"object"}]},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,12]]},"assertion":[{"value":"20 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics committee of Riyadh fertility and reproductive health center approved the protocol of the study.Informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}